ENTRY       D10358                      Drug
NAME        Momelotinib dihydrochloride (USAN)
FORMULA     C23H22N6O2. 2HCl
EXACT_MASS  486.1338
MOL_WEIGHT  487.3817
CLASS       Anti-inflammatory
             DG01985  Disease modifying anti-rheumatic drug (DMARD)
              DG02020  JAK inhibitor
            Metabolizing enzyme substrate
             DG01892  CYP1A2 substrate
             DG02918  CYP2C8 substrate
             DG01642  CYP2C9 substrate
             DG01639  CYP2C19 substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      Chemical structure group: DG01366
            Product (DG01366): D10889<US>
EFFICACY    Antineoplastic, Janus kinase (JAK) inhibitor
COMMENT     Treatment of myeloproliferative neoplasms
TARGET      JAK1 [HSA:3716] [KO:K11217]
            JAK2 [HSA:3717] [KO:K04447]
METABOLISM  Enzyme: CYP3A4 [HSA:1576], CYP2C8 [HSA:1558], CYP2C9 [HSA:1559], CYP2C19 [HSA:1557], CYP1A2 [HSA:1544]
INTERACTION  
BRITE       Drug groups [BR:br08330]
             Anti-inflammatory
              DG01985  Disease modifying anti-rheumatic drug (DMARD)
               DG02020  JAK inhibitor
                DG01366  Momelotinib
                 D10358  Momelotinib dihydrochloride
             Metabolizing enzyme substrate
              DG01892  CYP1A2 substrate
               DG01366  Momelotinib
                D10358  Momelotinib dihydrochloride
              DG02918  CYP2C8 substrate
               DG01366  Momelotinib
                D10358  Momelotinib dihydrochloride
              DG01642  CYP2C9 substrate
               DG01366  Momelotinib
                D10358  Momelotinib dihydrochloride
              DG01639  CYP2C19 substrate
               DG01366  Momelotinib
                D10358  Momelotinib dihydrochloride
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG01366  Momelotinib
                 D10358  Momelotinib dihydrochloride
            Target-based classification of drugs [BR:br08310]
             Protein kinases
              Non-receptor tyrosine kinases
               JAK family
                JAK1
                 D10358  Momelotinib dihydrochloride (USAN)
                JAK2
                 D10358  Momelotinib dihydrochloride (USAN)
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D10358
            Drug groups [BR:br08330]
             Anti-inflammatory
              DG01985  Disease modifying anti-rheumatic drug (DMARD)
               DG02020  JAK inhibitor
                DG01366  Momelotinib
             Metabolizing enzyme substrate
              DG01892  CYP1A2 substrate
               DG01366  Momelotinib
              DG02918  CYP2C8 substrate
               DG01366  Momelotinib
              DG01642  CYP2C9 substrate
               DG01366  Momelotinib
              DG01639  CYP2C19 substrate
               DG01366  Momelotinib
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG01366  Momelotinib
DBLINKS     CAS: 1380317-28-1
            PubChem: 172232451
ATOM        33
            1   C1x C     8.3427  -18.3059
            2   O2x O     8.3427  -19.7084
            3   C1x C     9.5572  -20.4096
            4   C1x C    10.7719  -19.7084
            5   N1y N    10.7719  -18.3059
            6   C1x C     9.5572  -17.6046
            7   C8y C    12.0052  -17.5936
            8   C8x C    13.2126  -18.2905
            9   C8x C    14.4271  -17.5892
            10  C8y C    14.4271  -16.1867
            11  C8x C    13.2197  -15.4897
            12  C8x C    12.0051  -16.1911
            13  N1b N    15.6471  -15.4820
            14  C8y C    16.8613  -16.1828
            15  N5x N    16.8619  -17.6042
            16  C8x C    18.0768  -18.3049
            17  C8x C    19.2912  -17.6031
            18  C8y C    19.2905  -16.1817
            19  N5x N    18.0756  -15.4810
            20  C8y C    20.4898  -15.4887
            21  C8x C    21.6982  -16.1860
            22  C8x C    22.9125  -15.4844
            23  C8y C    22.9122  -14.0819
            24  C8x C    21.7039  -13.3847
            25  C8x C    20.4894  -14.0862
            26  C5a C    24.1317  -13.3773
            27  N1b N    25.3469  -14.0783
            28  C1b C    26.5272  -13.3963
            29  C3b C    27.7257  -14.0879
            30  O5a O    24.1311  -11.9946
            31  N3a N    28.9381  -14.7879
            32  X   Cl   26.2500  -19.1100
            33  X   Cl   26.2500  -19.1100
BOND        34
            1     1   2 1
            2     2   3 1
            3     3   4 1
            4     4   5 1
            5     5   6 1
            6     1   6 1
            7     5   7 1
            8     7   8 2
            9     8   9 1
            10    9  10 2
            11   10  11 1
            12   11  12 2
            13    7  12 1
            14   10  13 1
            15   13  14 1
            16   14  15 1
            17   15  16 2
            18   16  17 1
            19   17  18 2
            20   18  19 1
            21   14  19 2
            22   18  20 1
            23   20  21 2
            24   21  22 1
            25   22  23 2
            26   23  24 1
            27   24  25 2
            28   20  25 1
            29   23  26 1
            30   26  27 1
            31   27  28 1
            32   28  29 1
            33   26  30 2
            34   29  31 3
BRACKET     1    24.3600  -20.1600   24.3600  -17.9200
            1    27.3000  -17.9200   27.3000  -20.1600
            1  2
  ORIGINAL  1   32
  REPEAT    1   33
///
